Mark A. Demitrack
2022
In 2022, Mark A. Demitrack earned a total compensation of $690.3K as SVP and Chief Medical Officer at Trevena, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $187,616 |
|---|---|
| Salary | $490,500 |
| Other | $12,200 |
| Total | $690,316 |
Demitrack received $490.5K in salary, accounting for 71% of the total pay in 2022.
Demitrack also received $187.6K in non-equity incentive plan and $12.2K in other compensation.
Rankings
In 2022, Mark A. Demitrack's compensation ranked 3,809th out of 5,759 executives tracked by ExecPay. In other words, Demitrack earned more than 33.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,809 out of 5,759 | 34th |
Division Manufacturing | 2,155 out of 3,135 | 31st |
Major group Chemicals And Allied Products | 1,038 out of 1,421 | 27th |
Industry group Drugs | 974 out of 1,322 | 26th |
Industry Pharmaceutical Preparations | 713 out of 968 | 26th |
Source: SEC filing on April 29, 2024.
Demitrack's colleagues
We found two more compensation records of executives who worked with Mark A. Demitrack at Trevena in 2022.